Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a
global imperative. Rapid immunization of the entire human population against a widespread, …

Background The repurposing of existing agents may accelerate TB drug development.
Recently, we reported that the lipid-lowering drug simvastatin, when added to the first-line …

Background Tuberculosis (TB) treatment is lengthy and complicated and patients often develop
chronic lung disease. Recent attention has focused on host-directed therapies aimed at …

The rise of drug-resistant tuberculosis poses a major risk to public health. Statins, which
inhibit both cholesterol biosynthesis and protein prenylation branches of the mevalonate …

Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), the causative agent
of coronavirus disease 19 (COVID-19), enters cells through attachment to the human …

Background The need to develop new, improved treatments for tuberculosis (TB) remains
urgent, and the repurposing of existing drugs represents a possible shortcut to market. …

Vitamin D has long been linked to resistance to tuberculosis, an infectious respiratory
disease that is increasingly hard to treat because of multidrug resistance. Previous work …

Foam cells are lipid-laden macrophages that contribute to the inflammation and tissue damage
associated with many chronic inflammatory disorders. Although foam cell biogenesis has …

Background We studied risk factors, antibodies, and symptoms of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in a diverse, ambulatory population. …

… Natalie Bruiners, 1, 3 Valentina Guerrini, 1, 3 Rahul Ukey, 1 Ryan Dikdan, 1 Jason Yang,
4, 5 Pankaj Kumar Mishra, 1 Alberta Onyuka, 2 Deborah Handler, 2 Joshua Vieth, 6 Mary …